Indaptus Therapeutics Inc

NASDAQ:INDP   3:26:40 PM EDT
5.15
+0.03 (+0.59%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Indaptus Therapeutics Inc Stock, NASDAQ:INDP

3 Columbus Circle, 15th Floor, New York, New York 10019
Israel
Phone: +1.646.374.8050
Number of Employees: 45

Description

Indaptus Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on research and development and clinical trials. The company develops formulations of drugs using its proprietary gastric retention technology, the Accordion Pill. The Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing efficient gastric retention. The company was founded by Michael James Newman on February 24, 2021 and is headquartered in New York, NY.